Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
95 participants
OBSERVATIONAL
2020-09-15
2022-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Randomized MINIMA Stem with DELTA TT or DELTA ST-C
NCT06870123
H-34 DELTA Revision Cup
NCT06359301
H-29 DELTA Multihole TT Study.
NCT05007067
28 mm Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement Study
NCT00208507
Minima Clinical Study
NCT02414542
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DELTA-ST cup in combination with MINIMA stem
Advance articular destruction generated by primary degenerative or post-traumatic arthrosis or reumatoid arthritis; fracture or avascular necrosis; congenital or acquired deformity.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both genders
* Any race
* A diagnosis in the target hip of one or more of the following:
1. Non-inflammatory degenerative joint disease such as osteoarthritis, avascular necrosis
2. Rheumatoid Arthritis
3. Post-traumatic arthritis
4. Fractures of femoral neck
5. Congenital or acquired deformity
* Patient willingness to participate
Exclusion Criteria
* Septicaemia
* Persistent acute or chronic osteomyelitis
* Confirmed nerve or muscle lesion compromising hip joint function
* Vascular or nerve diseases affecting the concerned limb
* Poor bone stock (for example due to osteoporosis) compromising the stability of the implant
* Metabolic disorders which may impair fixation and stability of the implant
* Any concomitant disease and dependence that might affect the implanted prosthesis
* Metal hypersensitivity to implant materials
* Required revision of previous standard femoral stem
* Age \< 18 years old
* Any clinically significant pathology based on clinical history that the Investigator feels may affect the study evaluation including, but not limited to:
1. significant neurological or musculoskeletal disorders or disease that may adversely affect gait and compromise functional recovery
2. neuromuscular or neurosensory deficit which would limit the ability to assess the performance of the device
3. known metabolic disorders leading to progressive bone deterioration
* Hip replacement on the contralateral side performed within less than one year
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Limacorporate S.p.a
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Psychiko Clinic (Athens Medical Group)
Athens, Psychiko, Greece
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Angeliki Syrigou
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-28
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.